查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493211

美国心室引流市场规模、份额、趋势分析报告：按应用、按患者类型、按最终用途、按国家、细分市场预测，2024-2030 年

U.S. External Ventricular Drain Market Size, Share & Trends Analysis Report By Application, By Patient Type, By End-use, By Country, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

美国心室引流（EVD）市场成长与趋势

根据Grand View Research, Inc.最新报告，预计到2030年，美国心室引流市场规模将达12亿美元，预测期内复合年增长率为8.10%。

该市场受到多种因素的推动，例如新产品的推出、医疗保健支出的增加以及用于治疗创伤性脑损伤的 EVD 设备的监管核准的增加。

在这个市场中，包括製造商、医疗保健提供者和监管机构在内的各种相关人员正在合作，以确保从各种类型出血中恢復的患者可以随时获得有效和安全的 EVD 解决方案。例如，2023 年 7 月，Integra LifeSciences 宣布对其 Codman Bactiseal EVD 导管套件在治疗水脑症共用取得的成功进行了积极评价，颅内动脉瘤破裂导致蜘蛛膜下腔出(aSAH) 患者常见的併发症。结果凸显了与使用这种医疗解决方案相关的积极的临床和经济成果。这项集体努力旨在提高受这种严重疾病影响的患者的整体护理品质和结果。

配戴 EVD 可以让医疗服务提供者持续监测颅骨内的压力，并做出必要的调整以排放液体。这种持续监测对于评估患者的神经状态并提供及时介入至关重要。

美国心室引流市场报告亮点

  • 从产品来看，创伤性脑损伤领域预计在预测期内复合年增长率最快，达到 9.50%。 TBI 可导致脑室内出血（出血），需要使用 EVD 设备清除大脑中多余的脑脊髓液。这将直接增加EVD设备的需求并推动市场成长。
  • 按患者类型划分，儿科领域预计在预测期内将以 9.56% 的复合年增长率增长最快，因为包括电脑断层扫描和MRI 在内的儿科神经影像技术的进步正在提高儿童TBI 诊断的准确性和及时性。
  • 医院在脑外伤、颅内压（ICP）和水脑症等神经系统疾病的诊断和治疗中发挥重要作用。作为患者照护的重要中心，这些设施通常拥有最先进的医疗技术并僱用熟练的医疗专业人员团队。

目录

第一章调查方法和范围

第二章执行概述

第三章美国心室引流市场变数、趋势、范围

  • 市场体系展望
    • 助剂市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
  • 美国心室引流市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国心室引流市场：应用、估计与趋势分析

  • 细分仪表板
  • 美国心室引流市场波动分析
  • 2018-2030 年美国心室引流市场规模与趋势分析（按应用）
  • 创伤性脑损伤
  • 蜘蛛网膜下腔出血
  • 脑出血
  • 其他非外伤性水脑症

第五章美国心室引流市场：病患类型、估计与趋势分析

  • 细分仪表板
  • 美国心室引流市场波动分析
  • 2018-2030 年美国心室引流市场规模与趋势分析（依病患类型）
  • 成人
  • 孩子

第六章美国心室引流市场：最终用途、估计与趋势分析

  • 细分仪表板
  • 美国心室引流市场波动分析
  • 2018-2030 年美国心室引流市场规模与趋势分析（依最终用途）
  • 医院
  • 其他的

第七章美国心室引流市场：国家估计和趋势分析（按应用、患者类型和最终用途）

  • 区域仪表板
  • 2018-2030年市场规模及趋势分析
  • 南部
  • 西
  • 中西部
  • 东北

第八章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Medtronic
    • Integra LifeSciences
    • SOPHYSA
    • Neuromedex
  • 热图分析/企业市场分析
  • 2023年企业市场占有率评估分析
  • 其他主要市场参与企业名单
Product Code: GVR-4-68040-264-4

U.S. External Ventricular Drain Market Growth & Trends:

The U.S. external ventricular drain market size is anticipated to reach USD 1.2 billion by 2030, exhibiting a CAGR of 8.10% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by various factors such as novel product launches, rising healthcare expenditure, and increasing regulatory approval for EVD devices in traumatic brain injury treatment.

In this market, various stakeholders, including manufacturers, healthcare providers, and regulatory bodies, collaborate to ensure that effective and safe EVD solutions are readily available for patients recovering from different types of hemorrhage. For instance, in July 2023, Integra LifeSciences shared positive updates about the successful application of the Codman Bactiseal EVD catheter set in managing hydrocephalus, a complication often seen in patients who have experienced aneurysmal Subarachnoid Hemorrhage (aSAH). The outcomes emphasized favorable clinical & economic results associated with the use of this medical solution. This collective effort aims to enhance the overall quality of care and outcomes for individuals affected by this serious medical condition.

By placing an EVD, healthcare providers can consistently monitor the pressure inside the skull and make necessary adjustments to fluid drainage. This ongoing monitoring is essential for evaluating the patient's neurological condition and ensuring timely interventions.

U.S. External Ventricular Drain Market Report Highlights:

  • Based on product, the traumatic brain Injury segment is expected to register the fastest CAGR of 9.50% during the forecast period. TBI can lead to intraventricular bleeding (hemorrhage), requiring the use of EVD devices to remove excess cerebrospinal fluid from the brain. This directly increases the demand for EVD devices, thereby fostering market growth.
  • Based on patient type, the pediatric segment is anticipated to grow at the fastest CAGR of 9.56% during the forecast period owing to the advancements in pediatric neuroimaging technologies, including CT scans & MRIs, which are improving the accuracy and timeliness of diagnosing TBIs in children.
  • Based on end-use, the hospital segment is expected to register the fastest CAGR of 8.32% during the forecast period.Hospitals play a crucial role in diagnosing & managing neurological disorders such as TBI, Intracranial Pressure (ICP), and hydrocephalus. Serving as pivotal centers for patient care, these facilities often possess state-of-the-art medical technology and employ a team of skilled healthcare specialists.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. External Ventricular Drain Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of neurological disorders
      • 3.2.1.2. Increasing healthcare expenditure
      • 3.2.1.3. Developments of novel EVD technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Infections and complications caused due to EVD insertion
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Growing awareness regarding neurological illnesses
      • 3.2.3.2. Increasing demand for minimally invasive procedures
  • 3.3. U.S. External Ventricular Drain Market Analysis Tools
    • 3.3.4. Industry Analysis - Porter's Five Forces
      • 3.3.4.1. Bargaining power of suppliers
      • 3.3.4.2. Bargaining power of buyers
      • 3.3.4.3. Threat of substitutes
      • 3.3.4.4. Threat of new entrants
      • 3.3.4.5. Competitive rivalry
    • 3.3.5. PESTEL Analysis
      • 3.3.5.1. Political & Legal Landscape
      • 3.3.5.2. Economic and Social Landscape
      • 3.3.5.3. Technological landscape

Chapter 4. U.S. External Ventricular Drain Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. External Ventricular Drain Market Movement Analysis
  • 4.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Traumatic Brain Injury
    • 4.4.1. Traumatic Brain Injury Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Subarachnoid Hemorrhage
    • 4.5.1. Subarachnoid Hemorrhage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Intracerebral Hemorrhage
    • 4.6.1. Intracerebral Hemorrhage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Other Non-traumatic Hydrocephalus Conditions
    • 4.7.1. Other Non-traumatic Hydrocephalus Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. External Ventricular Drain Market: Patient Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. External Ventricular Drain Market Movement Analysis
  • 5.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
  • 5.4. Adult
    • 5.4.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Pediatric
    • 5.5.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. External Ventricular Drain Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. External Ventricular Drain Market Movement Analysis
  • 6.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. External Ventricular Drain Market: Country Estimates & Trend Analysis by Application, By Patient Type, By End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size and Trend Analysis, 2018 to 2030
  • 7.3. South
    • 7.3.1. Key country dynamics
    • 7.3.2. Competitive scenario
    • 7.3.3. Regulatory framework
    • 7.3.4. Reimbursement scenario
    • 7.3.5. South Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. West
    • 7.4.1. Key country dynamics
    • 7.4.2. Competitive scenario
    • 7.4.3. Regulatory framework
    • 7.4.4. Reimbursement scenario
    • 7.4.5. West Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Midwest
    • 7.5.1. Key country dynamics
    • 7.5.2. Competitive scenario
    • 7.5.3. Regulatory framework
    • 7.5.4. Reimbursement scenario
    • 7.5.5. Midwest Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Northeast
    • 7.6.1. Key country dynamics
    • 7.6.2. Competitive scenario
    • 7.6.3. Regulatory framework
    • 7.6.4. Reimbursement scenario
    • 7.6.5. Northeast Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Integra LifeSciences
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. SOPHYSA
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Neuromedex
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
  • 8.3. Heat Map Analysis/ Company Market Position Analysis
  • 8.4. Estimated Company Market Share Analysis, 2023
  • 8.5. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. External ventricular drain market revenue estimates and forecast, by application, 2018 - 2030 (Million)
  • Table 4 U.S. External ventricular drain market revenue estimates and forecast, by patient type, 2018 - 2030 (Million)
  • Table 5 U.S. External ventricular drain market revenue estimates and forecast, by end use, 2018 - 2030 (Million)
  • Table 6 Key companies undergoing partnerships and collaborations
  • Table 7 Key companies undergoing product mergers and acquisitions
  • Table 8 Key companies undergoing product launch

List of Figures

  • Fig. 1 U.S. external ventricular drain market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market outlook
  • Fig. 9 Segment snapshot, 2023 & 2030 ( application and patient type)
  • Fig. 10 Segment snapshot, 2023 & 2030 (end use)
  • Fig. 11 Market concentration
  • Fig. 12 U.S. external ventricular drain market dynamics
  • Fig. 13 Porter's Five Forces analysis
  • Fig. 14 SWOT analysis, by factor (political, economic, social, technological, legal, and environmental)
  • Fig. 15 U.S. external ventricular drain market: By application Key takeaways
  • Fig. 16 U.S. external ventricular drain market, by application: Market Value, 2023 & 2030
  • Fig. 17 Traumatic brain injury market, 2018 - 2030 (USD Million)
  • Fig. 18 Subarachnoid hemorrhage market, 2018 - 2030 (USD Million)
  • Fig. 19 Intracerebral hemorrhage market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. external ventricular drain market: By patient type Key takeaways
  • Fig. 22 U.S. external ventricular drain market, by patient type market value, 2023 & 2030
  • Fig. 23 Adult market, 2018 - 2030 (USD Million)
  • Fig. 24 Pediatric market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. external ventricular drain market: By end use Key takeaways
  • Fig. 26 U.S. external ventricular drain market, by end use: Market value, 2023 & 2030
  • Fig. 27 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 Northeast market, 2018 - 2030 (USD Million)
  • Fig. 30 West market, 2018 - 2030 (USD Million)
  • Fig. 31 South market, 2018 - 2030 (USD Million)
  • Fig. 32 Midwest market, 2018 - 2030 (USD Million)
  • Fig. 33 Strategic framework